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Abstract Acute liver failure may be caused by a variety of
disorders including inborn errors of metabolism. In those
cases, rapid metabolic investigations and adequate treat-
ment may avoid the need for liver transplantation. We
report two patients who presented with acute liver failure
and were referred to our center for liver transplantation
work-up. Urgent metabolic investigations revealed citrulli-
nemia type I. Treatment for citrullinemia type I avoided the
need for liver transplantation. Acute liver failure as a
presentation of citrullinemia type I has not previously been
reported in young children. Although acute liver failure has
occasionally been described in other urea cycle disorders,
these disorders may be underestimated as a cause. Timely
diagnosis and treatment of these disorders may avoid liver
transplantation and improve clinical outcome. Therefore, urea
cycle disorders should be included in the differential diagnosis
in young children presenting with acute liver failure.
Introduction
Acute liver failure, for which liver transplantation is
considered, may be caused by a wide variety of diseases.
Among these are several inborn errors of metabolism
(Table 1). Recent reviews on acute liver failure in children
do not mention urea cycle disorders as a cause (Squires
2008; Dhawan 2008). We describe two unrelated patients
presenting with acute liver failure, who were referred for liver
transplantation. Urgent metabolic work-up revealed citrulli-
nemia type I (OMIM 215700). Treatment resulted in clinical
and biochemical improvement, thereby avoiding liver trans-
plantation. These case reports show the importance of urgent
and thorough metabolic investigations in young children with
acute liver failure referred for liver transplantation.
Patient 1
Patient 1 was a female Caucasian of healthy non-
consanguineous parents. After an uneventful pregnancy,
the patient’s mother was referred to a district hospital when
fetal decelerations were noted. Vaginal labor was acceler-
ated with vacuum- and forceps extraction. The child was
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born at 41+1 weeks gestation (birth weight 2,190 g, below
Z –2.5 SD; Apgar-scores 5-6-8). The umbilical cord pH of
7.19 quickly normalized after admission to the neonatal
ward. A cerebral CT revealed a right parietal fracture with
edema without intracerebral hemorrhages, compatible with
cerebral contusion due to complicated delivery.
At 5 days of age, the child started vomiting, and became
lethargic and hypotonic. At physical examination, slow
symmetric movements and absent orienting and acoustical
blink reflexes were noted. She was transferred to the
neonatal intensive care unit of a University Medical Center.
Laboratory evaluation showed liver parameter concentra-
tions of ALT 96 U/L (<45 U/L) and γGT 306 U/L (<50 U/L)
(reference values in parentheses; AST not determined). After
cessation of paracetamol, liver parameters decreased to ALT
13 U/L and γGT 35 U/L, respectively. Metabolic laboratory
evaluations were not performed. Brain MRI revealed
bilateral frontal and frontoparietal hemorrhages, with normal
myelinization and anatomy. She was discharged after
16 days.
At follow-up, she grew along the –2 SD curve, and was
delayed in developmental milestones. At 17 months of age,
she presented with fever without clear focus, refusal of
feeding, persistent vomiting, and diffuse itching. She was
alert, anicteric, and without abnormalities on physical
examination. Laboratory analysis showed the following
results (reference values in parentheses): leukocytes 27.5 ×
109/L (4.5–12.0 × 109/L), ESR 50 mm/h (<3–13 mm/h),
hemoglobin 5.7 mmol/L (6.5–8.4 mmol/L), glucose
5.4 mmol/L (4.0–7.8 mmol/L), creatinin 22 μmol/L (18–
35 μmol/L), urea 1.2 mmol/L (1.8–6.7 mmol/L), total
bilirubin 118 μmol/L (3–14 μmol/L), conjugated bilirubin
109 μmol/L (1–4 μmol/L), albumin 21 g/L (35–55 g/L),
AST 1,581 U/L (<40 U/L), ALT 2,070 U/L (<45 U/L),
γGT 192 U/L (<50 U/L), alkaline phosphatase 601 U/L
(55–250 U/L), LDH 1,087 U/L (<200 U/L), PTT 62 s (9–
12 s), and APTT 62 s (23–33 s). Arterial blood gas analysis
showed pH 7.45 (7.35–7.45), pCO2 5.2 kPa (4.6–6.0 kPa),
HCO3− 26.6 mmol/L (21–25 mmol/L), and BE +2.7 (−3.0
to +3.0). NH3 concentration was 114μmol/L (15–45μmol/L).
Abdominal ultrasound revealed no abnormalities.
An underlying metabolic disorder was suspected and the
child was eventually referred to the University Medical
Center Groningen (UMCG), so that, if necessary, liver
transplantation could be performed as soon as possible.
Metabolic analysis revealed glutamine 1,184 μmol/L (335–
810 μmol/L), citrulline 1,442 μmol/L (<50 μmol/L), and
arginine 23 μmol/L (10–110 μmol/L), and an urinary orotic
acid excretion of 656 μmol/mmol creatinine (undetectable
in healthy subjects). She was diagnosed with citrullinemia
type I. Treatment was started with intravenous infusion of
glucose, L-arginine, and oral sodium benzoate. Two days
later, enteral feeding with restriction of natural protein
intake was started. Concentrations of ammonia and trans-
aminases normalised within a few days and 3 weeks,
respectively. The child showed a marked clinical improve-
ment. Incorporation of 14C-citrulline in fibroblasts was
reduced to 7% of intra-assay control. DNA analyses are
pending.
Patient 2
Patient 2 was a male Caucasian born to non-consanguineous
parents. Patient 2 was born in the same district hospital as
patient 1, at 38+1 weeks after an uneventful gestation and
delivery, with birth weight 2,680 g (Z –1.3 SD), and Apgar
scores 9 and 10.
At 22 months of age, he presented with episodic
vomiting since 3 months, not obviously related to feeding,
Table 1 Inborn errors of metabolism that may present with acute liver failure and associated investigations
Disorder Suggested investigations
Tyrosinemia type Ia–c Blood succinylacetone; urinary OA, succinylacetone, δ-aminolevulinic acid
Urea cycle disordersa,d Blood ammonia, AA; urinary OA, purines/pyrimidines (orotic acid excretion)
Wilson’s diseaseb,c Blood copper and ceruloplasmin, urinary copper; consult ophthalmologist (evaluation for Kayser-Fleischer ring)
Neonatal hemochromatosisa,b Blood ferritin, transferrin, total iron binding capacity, iron
Galactosemiaa,b Blood galactose; galactose-1-phosphate in erythrocytes; urine sugar chromatogram
Heriditary fructose intolerancea Urinary AA, sugar chromatogram
Fatty acid oxidation disordersb,c Blood acylcarnitine analysis, urinary OA
Mitochondrial respiratory chain
deficiencya,b
Blood lactate, pyruvate, AA; urinary lactate; DNA-analysis mtDNA depletion, POLG mutations
α1-antitrypsin deficiencye Blood α1-antitrypsin
AA Amino acids, OA organic acids
Sources: a Durand et al. 2001; b Squires 2008; c Narkewicz et al. 2009; d Keskinen et al. 2008; e Fregonese and Stolk 2008. Full citations provided in the
References section
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with a frequency varying from daily to weekly. Further
history revealed increased fatigue, and a mild growth
retardation since the age of 8 months. Concerns were
raised about his development, since he was not able to walk
without support nor to throw a ball without losing balance.
At physical examination, the child was well and without
abnormalities. Laboratory results revealed leukocytes 10.7 ×
109/L, thrombocytes 378 × 109/L (150–350 × 109/L), Hb
7.2 mmol/L, glucose 4.9 mmol/L, Na + 138 mmol/L (138–
146 mmol/L), K + 4.3 mmol/L (4.1–5.5 mmol/L), Ca2 +
2.38 mmol/L (2.20–2.60 mmol/L), phosphate 1.58 mmol/L
(1.45–2.10 mmol/L), albumin 33 g/L, AST 206 U/L, ALT
323 U/L, and urea 2.5 mmol/L, capillary blood gas analysis
pH 7.47 (7.32–7.42), pCO2 3.8 kPa (5.5–6.8 kPa), HCO3−
20.2 mmol/L (24–28 mmol/L), and BE –2.1 mmol/L (−3.0
to +3.0), with NH3 210 μmol/L. Abdominal X-ray, barium
enema, abdominal ultrasound, screening results of viral
hepatitis and toxoplasmosis, and triple feces test were normal.
The patient was referred to an University Medical Center
considering an urea cycle disorder. As liver function
parameters deteriorated, the patient was referred the same
day to the UMCG for liver transplantation. Laboratory
evaluations revealed lactate 2.1 mmol/L (<2.0 mmol/L),
albumin 37 g/L, AST 757 U/L, ALT 1,315 U/L, γGT
38 U/L, alkaline phosphatase 285 U/L, INR 1.6 (0.8–1.3),
APTT 35 s, arterial blood gas analysis pH 7.38, with pCO2
4.8 kPa, and HCO3− 21 mmol/L, NH3 210 μmol/L,
glutamine 539 μmol/L, citrulline 1,963 μmol/L, and
arginine 51 μmol/L. Urine analysis revealed an orotic acid
excretion of 1,315 μmol/mmol creatinine. The boy was
diagnosed with citrullinemia type I. Treatment was started
with intravenous infusion of glucose and L-arginine, oral
sodium benzoate, and restriction of natural protein intake.
Within 2 days, the child improved markedly, and blood
concentrations of ammonia and liver parameters normalized.
Incorporation of 14C-citrulline in fibroblasts was reduced to
14% of intra-assay control. DNA analysis revealed the
c.685del8bp (fs232X) and c.815G > A (p.R272H) mutations
in the ASS-gene.
Discussion
To our knowledge, these two Caucasian patients with
citrullinemia type I are the first two presenting with acute liver
failure for which liver transplantation was considered. Thus
far, acute liver failure as a presentation of citrullinemia type I
has been reported once, in a patient diagnosed during
pregnancy (Dimmock et al. 2008). Pediatric acute liver failure
may be defined as “hepatic necrosis resulting in loss of liver
function within weeks or a few months of the onset of clinical
liver disease” (Whitington et al. 2008). In our patients,
synthetic liver function was compromised, as evident from
the coagulopathy and hypoalbuminemia present in both,
within the time frame mentioned in the definition. This
validates the diagnosis of acute liver failure in our patients.
Citrullinemia type I is caused by argininosuccinate
synthetase deficiency (E.C. 6.3.4.5), one of the six enzymes
that constitute the urea cycle. Urea cycle disorders usually
present with feeding problems, lethargy, convulsions, coma,
and death during the first days of life (Brusilow and
Horwich 2001). In addition, milder presentations at a later
age with failure to thrive, neurological symptoms, devel-
opmental delay and/or behavioral disorders have also been
described (Summar and Tuchman 2001).
In urea cycle disorders, acute liver failure is not generally
considered to be a presenting symptom (Saudubray et al.
2002; Endo et al. 2004; Olpin 2010). However, in contrast to
a statement made in a recent report (Olpin 2010), it should
be acknowledged that urea cycle disorders can present with
elevated transaminases and other biochemical signs of liver
pathology. In urea cycle disorders other than citrullinemia
type I, acute liver failure has occasionally been reported as
the presenting symptom (Keskinen et al. 2008; Durand et al.
2001). The pathogenesis of liver dysfunction in urea cycle
defects is unknown. It seems to be unrelated to the specific
enzymatic defect, intermediary metabolites, or the number of
hyperammonemic episodes, and may occur without con-
comitant hyperammonemia (Zamora et al. 1997; Kleijer et
al. 2002; Mori et al. 2002).
Retrospectively, one might suggest that the neurological
deterioration at day 5 in patient 1 was related to
citrullinemia type I. Blood ammonia was never measured
in this period, but she improved without any specific
treatment, and also, retrospectively, the cerebral MRI
performed at that time did not show abnormalities consistent
with citrullinemia type I.
In this report, we emphasize urea cycle disorders as a
cause of acute liver failure, particularly citrullinemia type I.
In 40–50% of patients presenting with acute liver failure, an
etiological diagnosis is not made (Squires 2008; Dhawan
2008). Urea cycle disorders may be underestimated as a
cause of acute liver failure. Our case report shows that
citrullinemia type I should be included in the differential
diagnosis of children presenting with acute liver failure.
The presentations of these two infants stress the importance
of urgent and thorough metabolic investigations in such
patients. Importantly, hyperammonemia in children with
acute liver failure may be caused by urea cycle disorders,
rather than be secondary to liver failure. An overview of
inborn errors of metabolism that may lead to acute liver
failure and associated investigations is presented in Table 1.
In conclusion, acute liver failure in children may be
caused by citrullinemia type I and other inborn errors of
metabolism. Adequate diagnosis and treatment may prevent
progression of liver failure and liver transplantation.
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